OSCR Stock Analysis: Buy, Sell, or Hold?
OSCR - Oscar Health, Inc.
$30.43
0.05 (0.16%)
▲
5d:
-0.46%
30d:
-2.22%
90d:
+69.62%
BUY
MODERATE Confidence
Analysis Updated: Aug 4, 2026 12:00 AM ET
Earnings: Aug 06, 2026
TODAY
Smart Money Accumulation
None View Scanner →
Strength: 7.7/10
Get Alerted When OSCR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: OSCR shows positive signals but monitor for confirmation. Market pricing in 10.3% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: OSCR shows positive signals but monitor for confirmation. Market pricing in 10.3% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$44.21
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$27.45
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: OSCR is currently trading at $30.43, which is considered fair relative to its 30-day fair value range of $29.21 to $31.46. From a valuation perspective, the stock is trading at a premium (Forward PE: 19.4) compared to its historical average (14.5). At these levels, the market is pricing in 10.3% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, OSCR is in a strong uptrend. Immediate support is located at $27.65, while resistance sits at $31.94.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $25.20. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, OSCR is in a strong uptrend. Immediate support is located at $27.65, while resistance sits at $31.94.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $25.20. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$29.21 -
$31.46
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
62.9%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 17.1% above Wall St target ($25.20)
- NEUTRAL: PE elevated vs history but 10.3% growth expectation is conservative given 126% recent growth
Trading Range Analysis
30-Day Trading Range
$29.21 -
$31.46
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$27.65
Resistance Level
$31.94
Current Trend
Strong Uptrend
Technical data as of
Aug 4, 2026
Fundamental Context
Forward P/E (Next Year Est.)
19.40
Wall Street Target
$25.20
(-17.1%)
Revenue Growth (YoY)
52.6%
Earnings Growth (YoY)
125.6%
Profit Margin
-0.3%
Valuation Premium vs History
+10.3% premium
PE vs Historical
19.4 vs 14.5
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+10.3%
(market-implied from PE analysis)
1-Year Target
$33.51
(+10%)
2-Year Target
$36.96
(+22%)
3-Year Target
$40.77
(+34%)
3-Yr Target (if PE normalizes)
(PE: 19→15)
PE COMPRESSION
$30.47
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: 41.0%)
$91.04
(+200%)
Base:
(SPY PE: 19.4, Growth: 41.0%)
$85.21
(+181%)
Bear:
(PE: 14.5, Growth: 41.0%)
$63.68
(+110%)
Share & Embed Analysis
Last updated: August 05, 2026 10:56 AM ET
Data refreshes hourly during market hours. Next update: 11:56 AM
Data refreshes hourly during market hours. Next update: 11:56 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OSCR showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Mark T Bertolini
BUY
1000000 shares
2026-04-06
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
28 analysts |
$114 | 52 HOLD |
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
27 analysts |
$475 | 49 HOLD |
|
CI
Cigna Corp |
STRONG BUY
25 analysts |
$343 | 47 HOLD |
|
ELV
Elevance Health Inc |
STRONG BUY
22 analysts |
$449 | 55 HOLD |
|
HUM
Humana Inc |
HOLD
26 analysts |
$408 | 57 HOLD |
Advanced OSCR Option Strategies
Professional options setups generated by AI based on today's OSCR price and gamma walls.
